CPhI Worldwide Opens Entries for 2018 Pharma Awards
CPhI Worldwide – organized by UBM (part of Informa PLC) – has announced the opening of the 2018 CPhI Pharma Awards for entries. The industry’s preeminent awards return for a landmark 15th edition, with 17 categories honouring companies and individuals driving the pharma industry forward through innovations, technologies, and strategies. This year's categories include: â Excellence in Pharma: CEO of the Year â Excellence in Pharma: Supply Chain, Logistics, and Distribution â Excellence in Pharma: Contract Services and Outsourcing â Excellence in Pharma: Regulatory Procedures and Compliance â Excellence in Pharma: Corporate Social Responsibility â Excellence in Pharma: Pharma Company of the Year â Excellence in Pharma: OTC â Excellence in Pharma: Patient Centricity â Excellence in Pharma: IT, mHealth & Digitalisation Last year, the awards received a record number of submissions (over 200 applications). CPhI Worldwide is expecting greater interest in 2018. Former winners of the CEO of the year award include Vivek Sharma, CEO of Piramal (winner in 2015); Udit Batra, CEO of Merck (winner in 2016), and last year Richard Chin, MD, founder and CEO of Kindred Biosciences. Another increasingly significant category is the Corporate Social Responsibility award, which will be given in partnership with official charity partner, International Medical Corps. Orhan Caglayan, Brand Director – CPhI Worldwide, UBM (part of Informa PLC), commented: “The awards are now rightly lauded as the most prestigious in pharma. If you or your company want to be recognized amongst the industry and your peers as driving forward developments, we encourage you to take part – all pharma and supply chain companies are welcome.” Submitting your entry(ies) for the CPhI Pharma Awards is free of charge and the deadline is July 31, 2018 – with shortlisted finalists announced August 28, 2018. The winners will be unveiled during a ceremony at the prestigious Eurostars Madrid Tower in Madrid, on October 9th during the evening of the first day of CPhI Worldwide. To apply please visit https://awards.cphi.com
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
